Purpose To determine whether prilocaine is a more comfortable local infiltration anaesthetic agent than the more widely used lignocaine for minor eyelid procedures. 
similar to that of lignocaine but it has a slower systemic absorption, is therefore less toxic and avoids the requirement for adrenaline? In addition its only potentially serious side-effect, that of methaemoglobinaemia, requires volumes never reached when used for ophthalmological purposes?
In our constant pursuit of improved quality of patient care, it is of little surprise that we continue to try to find ways of reducing discomfort during local anaesthesia. Much has been published regarding the warming-and buffering7 of anaesthetic solutions in order to reduce patient discomfort during infiltration.
Surprisingly it has been shown that the speed of infiltration,8 concentration9 and volumelo of local anaesthetic agent used do not significantly affect discomfort. Informed consent was obtained. The assisting nurse randomly drew up 1 rn1 of either 2% lignocaine plain or 2% prilocaine plain into a 2.5 ml syringe mounted with a 25 gauge needle.
The surgeon and patient were masked as to which agent was being used. All solutions used were at room temperature (17-21 QC).
A standard set of instructions was read out to each patient prior to the procedure, outlining the aims of the study and explaining that it was the discomfort of the actual injection and not the transdermal insertion of the needle that was to be recorded. At the end of the procedure the nurse disclosed which anaesthetic agent was used and a data sheet was completed. The results were analysed using the Mann-Whitney U-test for non-parametric data. 
Results
Of the 125 patients recruited, 66 were eventually allocated to the prilocaine group and 59 to the lignocaine group. The results are summarised in Table 2 and Fig. 1 . The mean pain score for the prilocaine group was 1.82, while that of the lignocaine group was 3.19. The
Mann-Whitney U-test for significance showed U = 1236.5 and p < 0.001 ( Table 3 ). The median pain score for the prilocaine group was 1.00 whilst that for the lignocaine group was 3.00. In all cases adequate anaesthesia was achieved and maintained throughout the procedure. The results of our study show that there is a significant reduction in patient discomfort with the use of prilocaine as a local anaesthetic agent when compared with lignocaine for minor eyelid procedures. During the pilot study more extensive procedures such as entropion/ ectropion correction were included. These were subsequently removed from the study. Although good anaesthesia was achieved initially, its effect began to subside before completion of the procedure.
Although the numbers were not significant, it was reassuring that the two patients who happened to attend twice during the course of the study showed consistency of their results and supported our conclusion that prilocaine is a more comfortable local anaesthetic to administer than lignocaine. It is difficult to ascertain why prilocaine should be less painful than lignocaine on injection as the two agents are very similar in most respects. They share a very similar molecular structure (Fig. 2) and are both basic compounds with identical ionisation constants (pKa = 7.9). It is possible that lignocaine produces more pain on injection because of a greater local vasodilator effect than prilocaine. If this were the case, it would be interesting to determine whether the addition of adrenaline reduces the pain induced by plain lignocaine infiltration.
This study supports prilocaine as a superior local anaesthetic agent to lignocaine for the purposes of minor eyelid procedures. It is as effective, less toxic 2 and is less painful to administer.
